Product Name: MBX-2982 featured
Description: MBX-2982, also known as SAR-260093, is a potential first-in-class treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. P
CAS NO: 861875-60-7 Product: NVP-BAW2881
Synonym: MBX-2982; MBX 2982; MBX2982; SAR-260093; SAR260093; SAR 260093
IUPAC Chemical Name: 4-((4-(1H-tetrazol-1-yl)phenoxy)methyl)-2-(1-(5-ethylpyrimidin-2-yl)piperidin-4-yl)thiazole
In ChiKey: NFTMKHWBOINJGM-UHFFFAOYSA-NApoptosis inhibitors
SMILE Code: CCC1=CN=C(N2CCC(C3=NC(COC4=CC=C(N5N=NN=C5)C=C4)=CS3)CC2)N=C1
Appearance: Solid powder
Purity: 98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.Medchemexpress.com
Storage Condition: Dry, dark and at 0 – 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: 2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 – 4 C for short term (days to weeks), or -20 C for long term (months).PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22134262
Chemical Formula：C22H24N8OS
ExactMass: 448.17938
Molecular Weight: 448.54396
Elemental Analysis: C, 58.91; H, 5.39; N, 24.98; O, 3.57; S, 7.15
bet-bromodomain.com
BET Bromodomain Inhibitor
